STAT4 gene polymorphisms are associated with susceptibility and ANA status in primary biliary cirrhosis

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Joshita, Satoru ^a   Umemura, Takeji ^a   Nakamura, Minoru ^b   Katsuyama, Yoshihiko ^c   Shibata, Soichiro ^a   Kimura, Takefumi ^a   Morita, Susumu ^a   Komatsu, Michiharu ^a   Matsumoto, Akihiro ^a   Yoshizawa, Kaname ^a   Ishibashi, Hiromi ^b   Tanaka, Eiji ^a   Ota, Masao ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; INTERLEUKIN 12P35; INTERLEUKIN 12P40; MITOCHONDRION ANTIBODY; STAT4 PROTEIN; IL12A PROTEIN, HUMAN; IL12RB1 PROTEIN, HUMAN; INTERLEUKIN 12 RECEPTOR; STAT4 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; BILIARY CIRRHOSIS; BLOOD; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; JAPAN;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-12 SUBUNIT P35; JAPAN; LINKAGE DISEQUILIBRIUM; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-12; STAT4 TRANSCRIPTION FACTOR;

EID: 84896977240     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/727393     Document Type: Article

References (46)

1. Kaplan M. M., Gershwin M. E., Primary biliary cirrhosis. New England Journal of Medicine 2005 353 12 1261 1273 2-s2.0-25144474552 10.1056/NEJMra043898
2. Selmi C., Mayo M. J., Bach N., Ishibashi H., Invernizzi P., Gish R. G., Gordon S. C., Wright H. I., Zweiban B., Podda M., Gershwin M. E., Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004 127 2 485 492 2-s2.0-4143103585 10.1053/j.gastro.2004.05.005
3. Invernizzi P., Selmi C., Mackay I. R., Podda M., Gershwin M. E., From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clinical Gastroenterology and Hepatology 2005 3 5 401 410 2-s2.0-18144383173 10.1016/S1542-3565(04)00678-0
4. Hirschfield G. M., Invernizzi P., Progress in the genetics of primary biliary cirrhosis. Seminars in Liver Disease 2011 31 2 147 156 2-s2.0-79955634917 10.1055/s-0031-1276644
5. Umemura T., Joshita S., Ichijo T., Yoshizawa K., Katsuyama Y., Tanaka E., Ota M., Ichikawa-Yamada Y., Kimura T., Morita S., Kamijo A., Komatsu M., Matsumoto A., Yamamura N., Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis. Hepatology 2012 55 2 506 511 2-s2.0-84856375987 10.1002/hep.24705
6. Joshita S., Umemura T., Yoshizawa K., Katsuyama Y., Tanaka E., Ota M., A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients. Human Immunology 2010 71 5 520 524 2-s2.0-77951905872 10.1016/j.humimm.2010.02.009
7. Joshita S., Umemura T., Yoshizawa K., Katsuyama Y., Tanaka E., Nakamura M., Ishibashi H., Ota M., Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. Journal of Hepatology 2010 53 3 537 541 2-s2.0-77955847602 10.1016/j.jhep.2010. 03.017
8. Hirschfield G. M., Liu X., Xu C., Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. New England Journal of Medicine 2009 360 2544 2555 10.1056/NEJMoa0810440
9. Hirschfield G. M., Liu X., Han Y., Gorlov I. P., Lu Y., Xu C., Lu Y., Chen W., Juran B. D., Coltescu C., Mason A. L., Milkiewicz P., Myers R. P., Odin J. A., Luketic V. A., Speiciene D., Vincent C., Levy C., Gregersen P. K., Zhang J., Heathcote E. J., Lazaridis K. N., Amos C. I., Siminovitch K. A., Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nature Genetics 2010 42 8 655 657 2-s2.0-77955087537 10.1038/ng.631
10. Liu X., Invernizzi P., Lu Y., Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nature Genetics 2010 42 658 660 10.1038/ng.627
11. Mells G. F., Floyd J. A. B., Morley K. I., Cordell H. J., Franklin C. S., Shin S.-Y., Heneghan M. A., Neuberger J. M., Donaldson P. T., Day D. B., Ducker S. J., Muriithi A. W., Wheater E. F., Hammond C. J., Dawwas M. F., Jones D. E., Peltonen L., Alexander G. J., Sandford R. N., Anderson C. A., Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nature Genetics 2011 43 329 332 10.1038/ng.789
12. Nakamura M., Nishida N., Kawashima M., Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population. American Journal of Human Genetics 2012 91 721 728 10.1016/j.ajhg.2012.08.010
13. Yamamoto K., Quelle F. W., Thierfelder W. E., Kreider B. L., Gilbert D. J., Jenkins N. A., Copeland N. G., Silvennoinen O., Ihle J. N., Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Molecular and Cellular Biology 1994 14 7 4342 4349 2-s2.0-0028228543
14. Kaplan M. H., STAT4: a critical regulator of inflammation in vivo. Immunologic Research 2005 31 3 231 242 2-s2.0-18244392419 10.1385/IR:31:3:231
15. Bacon C. M., Petricoin E. F. III, Ortaldo J. R., Rees R. C., Larner A. C., Johnston J. A., O'Shea J. J., Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 1995 92 16 7307 7311 2-s2.0-0029116336 10.1073/pnas.92.16.7307
16. Wurster A. L., Tanaka T., Grusby M. J., The biology of Stat4 and Stat6. Oncogene 2000 19 21 2577 2584 2-s2.0-0034658501
17. van Norstrand M. D., Malinchoc M., Lindor K. D., Therneau T. M., Gershwin M. E., Leung P. S. C., Dickson E. R., Homburger H. A., Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression. Hepatology 1997 25 1 6 11 2-s2.0-0031029761
18. Muratori P., Muratori L., Ferrari R., Cassani F., Bianchi G., Lenzi M., Rodrigo L., Linares A., Fuentes D., Bianchi F. B., Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. American Journal of Gastroenterology 2003 98 2 431 437 2-s2.0-0037283230 10.1111/j.1572-0241. 2003.07257.x
19. Nakamura M., Kondo H., Mori T., Komori A., Matsuyama M., Ito M., Takii Y., Koyabu M., Yokoyama T., Migita K., Daikoku M., Abiru S., Yatsuhashi H., Takezaki E., Masaki N., Sugi K., Honda K., Adachi H., Nishi H., Watanabe Y., Nakamura Y., Shimada M., Komatsu T., Saito A., Saoshiro T., Harada H., Sodeyama T., Hayashi S., Masumoto A., Sando T., Yamamoto T., Sakai H., Kobayashi M., Muro T., Koga M., Shums Z., Norman G. L., Ishibashi H., Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007 45 1 118 127 2-s2.0-33846449067 10.1002/hep.21472
20. Nakamura M., Shimizu-Yoshida Y., Takii Y., Komori A., Yokoyama T., Ueki T., Daikoku M., Yano K., Matsumoto T., Migita K., Yatsuhashi H., Ito M., Masaki N., Adachi H., Watanabe Y., Nakamura Y., Saoshiro T., Sodeyama T., Koga M., Shimoda S., Ishibashi H., Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. Journal of Hepatology 2005 42 3 386 392 2-s2.0-13844289482 10.1016/j.jhep.2004.11.016
21. Aiba Y., Nakamura M., Joshita S., Inamine T., Komori A., Yoshizawa K., Umemura T., Horie H., Migita K., Yatsuhashi H., Nakamuta M., Fukushima N., Saoshiro T., Hayashi S., Kouno H., Ota H., Muro T., Watanabe Y., Nakamura Y., Komeda T., Shimada M., Masaki N., Komatsu T., Yagura M., Sugi K., Koga M., Tsukamoto K., Tanaka E., Ishibashi H., PBC Study Group in NHOSLJ P. S. G. I. N., Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients. Journal of Gastroenterology 2011 46 10 1203 1212 10.1007/s00535-011-0417-7 2-s2.0-84857216764
22. Morita S., Joshita S., Umemura T., Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis. Human Immunology 2013 74 2 219 222 10.1016/j.humimm.2012.10.022
23. Inamine T., Nakamura M., Kawauchi A., A polymorphism in the integrin alphaV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients. Journal of Gastroenterology 2011 46 5 676 686 10.1007/s00535-010-0351-0
24. Ohishi Y., Nakamuta M., Ishikawa N., Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients. Journal of Gastroenterology 2013 10.1007/s00535-013-0795-0
25. Inamine T., Higa S., Noguchi F., Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients. Journal of Gastroenterology 2013 48 10 1160 1170 10.1007/s00535-012- 0730-9
26. Lindor K. D., Gershwin M. E., Poupon R., Kaplan M., Bergasa N. V., Heathcote E. J., Primary biliary cirrhosis. Hepatology 2009 50 1 291 308 2-s2.0-67651160903 10.1002/hep.22906
27. Umemura T., Zen Y., Hamano H., Kawa S., Nakanuma Y., Kiyosawa K., Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007 46 2 463 471 2-s2.0-34548314059 10.1002/hep.21700
28. Ota M., Seki T., Nomura N., Sugimura K., Mizuki N., Fukushima H., Tsuji K., Inoko H., Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 1991 38 2 60 71 2-s2.0-0025862373
29. Remmers E. F., Plenge R. M., Lee A. T., Graham R. R., Hom G., Behrens T. W., De Bakker P. I. W., Le J. M., Lee H.-S., Batliwalla F., Li W., Masters S. L., Booty M. G., Carulli J. P., Padyukov L., Alfredsson L., Klareskog L., Chen W. V., Amos C. I., Criswell L. A., Seldin M. F., Kastner D. L., Gregersen P. K., STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. New England Journal of Medicine 2007 357 10 977 986 2-s2.0-34548427925 10.1056/NEJMoa073003
30. Kobayashi S., Ikari K., Kaneko H., Kochi Y., Yamamoto K., Shimane K., Nakamura Y., Toyama Y., Mochizuki T., Tsukahara S., Kawaguchi Y., Terai C., Hara M., Tomatsu T., Yamanaka H., Horiuchi T., Tao K., Yasutomo K., Hamada D., Yasui N., Inoue H., Itakura M., Okamoto H., Kamatani N., Momohara S., Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. Arthritis and Rheumatism 2008 58 7 1940 1946 2-s2.0-47249119222 10.1002/art.23494
31. Sigurdsson S., Nordmark G., Garnier S., Grundberg E., Kwan T., Nilsson O., Eloranta M.-L., Gunnarsson I., Svenungsson E., Sturfelt G., Bengtsson A. A., Jönsen A., Truedsson L., Rantapää-Dahlqvist S., Eriksson C., Alm G., Göring H. H. H., Pastinen T., Syvänen A.-C., Rönnblom L., A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Human Molecular Genetics 2008 17 18 2868 2876 2-s2.0-50849101942 10.1093/hmg/ddn184
32. Barrett J. C., Fry B., Maller J., Daly M. J., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 2 263 265 2-s2.0-13444269543 10.1093/bioinformatics/bth457
33. Gabriel S. B., Schaffner S. F., Nguyen H., Moore J. M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S. N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E. S., Daly M. J., Altshuler D., The structure of haplotype blocks in the human genome. Science 2002 296 5576 2225 2229 2-s2.0-18444369013 10.1126/science.1069424
34. Taylor K. E., Chung S. A., Graham R. R., Ortmann W. A., Lee A. T., Langefeld C. D., Jacob C. O., Kamboh M. I., Alarcón-Riquelme M. E., Tsao B. P., Moser K. L., Gaffney P. M., Harley J. B., Petri M., Manzi S., Gregersen P. K., Behrens T. W., Criswell L. A., Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genetics 2011 7 2 2-s2.0-79952261842 10.1371/journal.pgen. 1001311 e1001311
35. Alonso-Perez E., Suarez-Gestal M., Calaza M., Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PloS ONE 2012 7 9 e45356 10.1371/journal.pone. 0045356
36. Lamana A., Balsa A., Rueda B., The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis. PloS ONE 2012 7 8 e43661 10.1371/journal.pone.0043661
37. Shen L., Liu R., Zhang H., Huang Y., Sun R., Tang P., Replication study of STAT4 rs7574865 G/T polymorphism and risk of rheumatoid arthritis in a Chinese population. Gene 2013 526 2 259 264 10.1016/j.gene.2013.05.022
38. Tong G., Zhang X., Tong W., Liu Y., Association between polymorphism in STAT4 gene and risk of rheumatoid arthritis: a meta-analysis. Human Immunology 2013 74 5 586 592 10.1016/j.humimm.2012.11.033
39. Liu J. Z., Almarri M. A., Gaffney D. J., Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nature Genetics 2012 44 1137 1141 10.1038/ng.2395
40. Juran B. D., Hirschfield G. M., Invernizzi P., Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Human Molecular Genetics 2012 21 5209 5221 10.1093/hmg/dds359
41. Tanaka A., Invernizzi P., Ohira H., Kikuchi K., Nezu S., Kosoy R., Seldin M. F., Gershwin M. E., Takikawa H., Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort. Tissue Antigens 2011 78 1 65 68 2-s2.0-79958769177 10.1111/j.1399-0039.2011.01684.x
42. Mells G. F., Floyd J. A. B., Morley K. I., Cordell H. J., Franklin C. S., Shin S.-Y., Heneghan M. A., Neuberger J. M., Donaldson P. T., Day D. B., Ducker S. J., Muriithi A. W., Wheater E. F., Hammond C. J., Dawwas M. F., Jones D. E., Peltonen L., Alexander G. J., Sandford R. N., Anderson C. A., Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nature Genetics 2011 43 11 1164
43. Peters M. G., Di Bisceglie A. M., Kowdley K. V., Flye N. L., Luketic V. A., Munoz S. J., Garcia-Tsao G., Boyer T. D., Lake J. R., Bonacini M., Combes B., Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States. Hepatology 2007 46 3 769 775 2-s2.0-34548772862 10.1002/hep.21759
44. Liu B., Zhang F. C., Zhang Z. L., Zhang W., Gao L. X., Interstitial lung disease and Sjögren's syndrome in primary biliary cirrhosis: a causal or casual association? Clinical Rheumatology 2008 27 10 1299 1306 2-s2.0-51549089974 10.1007/s10067-008-0917-x
45. Caramella C., Avouac J., Sogni P., Puéchal X., Kahan A., Allanore Y., Association between rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 2007 74 3 279 281 2-s2.0-34248369277 10.1016/j.jbspin.2006.06. 012
46. Mayo M. J., Jenkins R. N., Combes B., Lipsky P. E., Association of clonally expanded T cells with the syndrome of primary biliary cirrhosis and limited scleroderma. Hepatology 1999 29 6 1635 1642 2-s2.0-0033065766 10.1002/hep.510290637